Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platform.

Molecular therapy. Advances·2026

Same author

Sickle Cell Disease: Historical Overview and Current Therapies.

Prenatal diagnosis·2026

Same author

Evaluation of Maternal Safety Following Prenatal Cell and Gene Therapy for Hemophilia A.

Prenatal diagnosis·2026

Same author

In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current Therapies.

Prenatal diagnosis·2026

Same author

Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse events.

Frontiers in immunology·2026

Same author

Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing.

Stem cells translational medicine·2025

Search research articles

Related Experiment Video

Updated: May 12, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Mesenchymal stem cells engineered to inhibit complement-mediated damage.

Melisa A Soland¹, Mariana Bego, Evan Colletti

¹Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.

|April 5, 2013

Summary

This summary is machine-generated.

Engineering mesenchymal stem cells (MSCs) with human cytomegalovirus (HCMV) US2 protein enhances their survival. This strategy protects MSCs from complement-mediated lysis, improving their therapeutic potential in tissue repair.

More Related Videos

An Enzymatic Method to Rescue Mesenchymal Stem Cells from Clotted Bone Marrow Samples

An Enzymatic Method to Rescue Mesenchymal Stem Cells from Clotted Bone Marrow Samples

Published on: April 12, 2015

Related Experiment Videos

Last Updated: May 12, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

An Enzymatic Method to Rescue Mesenchymal Stem Cells from Clotted Bone Marrow Samples

An Enzymatic Method to Rescue Mesenchymal Stem Cells from Clotted Bone Marrow Samples

Published on: April 12, 2015

Area of Science:

Immunology and Regenerative Medicine

Background:

Mesenchymal stem cells (MSCs) are crucial for tissue repair due to their immunomodulatory and trophic properties.
MSCs express complement regulatory proteins (CD46, CD55, CD59) but can be damaged by complement activation after transplantation.
Previous work showed HCMV-US protein transduction increased MSC engraftment by reducing HLA-I expression.

Purpose of the Study:

To investigate if engineering MSCs to express HCMV-US proteins (US2, US3, US6, US11) can enhance complement evasion.
To determine if this engineering protects MSCs from complement-mediated lysis, thereby improving therapeutic efficacy.

Main Methods:

MSCs were transduced with retroviruses encoding HCMV-US proteins (US2, US3, US6, US11).
Flow cytometry was used to evaluate the expression of complement regulatory proteins (CD46, CD55, CD59).
A complement-mediated cytotoxicity assay assessed the lysis of engineered MSCs.

Main Results:

HCMV-US proteins increased CD59 expression in MSCs, with significant increases in MSC-US2, MSC-US3, and MSC-US6.
MSC-US2 showed increased CD46 expression, while US2 and US3 augmented the percentage of MSCs expressing CD46.
Over-expression of US2 protein reduced complement-mediated lysis of MSCs by 59.10±12.89%.

Conclusions:

HCMV-US proteins, particularly US2, can enhance MSC expression of complement regulatory proteins.
Engineering MSCs with HCMV-US2 significantly protects them from complement-mediated lysis.
Over-expression of HCMV-US2 on MSCs represents a novel strategy to improve their survival and therapeutic potential.